These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33865751)

  • 1. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention.
    Abu-Assi E; Raposeiras-Roubín S; Cespón Fernández M; Caneiro Queija B; Melendo Viu M; Íñiguez Romo A
    Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):375-383. PubMed ID: 33865751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.
    Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M
    J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition.
    Gragnano F; Spirito A; Corpataux N; Vaisnora L; Galea R; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Bär S; Ueki Y; Capodanno D; Urban P; Pocock SJ; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M
    EuroIntervention; 2021 Dec; 17(11):e898-e909. PubMed ID: 34105513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
    Ueki Y; Bär S; Losdat S; Otsuka T; Zanchin C; Zanchin T; Gragnano F; Gargiulo G; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Heg D; Valgimigli M; Windecker S; Räber L
    EuroIntervention; 2020 Aug; 16(5):371-379. PubMed ID: 32065586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
    Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.
    Nicolas J; Beerkens F; Cao D; Sartori S; Pivato CA; Qiu H; Giustino G; Chiarito M; Claessen BE; Zhang Z; Nardin M; Razuk V; Jones D; Camaj A; Power D; Banashefski B; Sweeny J; Baber U; Dangas G; Sharma SK; Kini A; Mehran R
    J Thromb Thrombolysis; 2022 Jan; 53(1):20-29. PubMed ID: 34347202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.
    Cao D; Mehran R; Dangas G; Baber U; Sartori S; Chandiramani R; Stefanini GG; Angiolillo DJ; Capodanno D; Urban P; Morice MC; Krucoff M; Goel R; Roumeliotis A; Sweeny J; Sharma SK; Kini A
    J Am Coll Cardiol; 2020 Jun; 75(21):2711-2722. PubMed ID: 32466887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in patients undergoing peripheral endovascular interventions.
    Tomoi Y; Kuramitsu S; Shinozaki T; Soga Y; Kodama K; Imada K; Hiramori S; Ando K
    EuroIntervention; 2023 Apr; 18(16):e1368-e1377. PubMed ID: 36579610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry.
    Nakamura M; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Iijima R; Harada A; Kuroda T; Murakami Y
    EuroIntervention; 2021 Feb; 16(14):1154-1162. PubMed ID: 32624464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk.
    Corpataux N; Spirito A; Gragnano F; Vaisnora L; Galea R; Svab S; Gargiulo G; Zanchin T; Zanchin C; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Räber L; Capodanno D; Urban P; Pocock S; Heg D; Windecker S; Valgimigli M
    Eur Heart J; 2020 Oct; 41(38):3743-3749. PubMed ID: 33029615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention　- From the CREDO-Kyoto Registry Cohort-3.
    Natsuaki M; Morimoto T; Shiomi H; Ehara N; Taniguchi R; Tamura T; Tada T; Suwa S; Kaneda K; Watanabe H; Tazaki J; Watanabe S; Yamamoto E; Saito N; Fuki M; Takeda T; Eizawa H; Shinoda E; Mabuchi H; Shirotani M; Uegaito T; Matsuda M; Takahashi M; Inoko M; Tamura T; Ishii K; Onodera T; Sakamoto H; Aoyama T; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
    Circ J; 2021 May; 85(6):769-781. PubMed ID: 33298644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent.
    Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients with Acute Myocardial Infarction.
    Matsumoto T; Saito Y; Sato T; Yamashita D; Suzuki S; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
    J Atheroscler Thromb; 2023 Mar; 30(3):299-309. PubMed ID: 35613875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
    Silverio A; Di Maio M; Buccheri S; De Luca G; Esposito L; Sarno G; Vecchione C; Galasso G
    Int J Cardiol; 2022 Jan; 347():8-15. PubMed ID: 34774882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis.
    Montalto C; Munafò AR; Arzuffi L; Casula M; Mandurino-Mirizzi A; Costa F; Leonardi S; Oltrona Visconti L; Ferlini M
    Hellenic J Cardiol; 2022; 66():59-66. PubMed ID: 35550178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
    Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N
    Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of the Academic Research Consortium for High Bleeding Risk Criteria and Prognostic Value of a Simplified Definition.
    Miura K; Shimada T; Ohya M; Murai R; Amano H; Kubo S; Tada T; Tanaka H; Fuku Y; Goto T; Kadota K
    Circ J; 2020 Aug; 84(9):1560-1567. PubMed ID: 32669530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal variations in ischemic and bleeding event risks after acute coronary syndrome during dual antiplatelet therapy.
    Fujii T; Kasai S; Kawamura Y; Yoshimachi F; Ikari Y
    Int J Cardiol; 2023 Dec; 392():131340. PubMed ID: 37678433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the Academic Research Consortium high bleeding risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities.
    Hashimoto R; Numasawa Y; Yokokura S; Daigo K; Sakata S; Imaeda S; Hitomi Y; Sato K; Taruoka A; Haginiwa S; Kojima H; Tanaka M; Kuno T; Kodaira M
    Heart Vessels; 2021 Sep; 36(9):1350-1358. PubMed ID: 33651134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.